DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Repro India Limited — Outcome of Board Meeting

NSE 2 hrs ago·4 Aug 2026, 8:16 am

Repro India

Repro India Limited has informed the stock exchanges about its financial results for the period ending June 30, 2026. This announcement marks the formal disclosure of the company's performance during this specific quarter.

For investors, this update is crucial as it provides the first detailed look at the company's operational health and financial standing for the latest quarter. It helps in assessing the current trajectory of the business and its ability to meet market expectations.

Investors should focus on the key performance indicators within the results, such as revenue growth and profit margins, to gauge the company's operational efficiency. Keeping an eye on management commentary regarding future outlooks will also be important for understanding the company's direction.